Jun 22, 2021 / 05:20PM GMT
Dane Leone - Raymond James & Associates, Inc. - Analyst
Great. Thanks, everyone, for joining us for the next session here at Raymond James 2021 Human Health Innovation Conference.
Really excited to have with me for a fireside chat, Brian Culley, CEO of Lineage Cell Therapeutics; doing a lot of exciting things but have had a number of interesting clinical updates recently around dry AMD geographic atrophy program that is an incredibly large unmet need. So new treatments are definitely of the highest importance here.
Maybe for the audience that doesn't know the Lineage Cell Therapeutics story as well, you -- Brian, if you can provide just a little bit of background of yourself and an overview of the Company.
Brian Culley - Lineage Cell Therapeutics, Inc. - CEO
Well, thanks, Dane. It's certainly our pleasure to be participating today.
I started in the lab -- I was a lab coat-wearing bench scientist for many years at places like Scripps Research and Neurocrine Biosciences, and then through business development eventually became a
Lineage Cell Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers